D.E. Shaw & Co
CMLTU

D.E. Shaw & Co’s CM Life Sciences III Inc. Unit CMLTU Stock Holding History

D.E. Shaw & Co’s Portfolio CMLTU Stock Details CMLTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,250,000
Closed -$13.7M – 5535
2021
Q2 		$13.7M Buy
+1,250,000
New +$13.5M 0.01% 1246

Other funds holding CMLTU

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

D.E. Shaw & Co's CMLTU Position: Q3 2021 in Review

D.E. Shaw & Co sold out of CM Life Sciences III Inc. Unit (CMLTU) in Q3 2021, closing a stake of 1,250,000 shares — an estimated $13.7M sold.

D.E. Shaw & Co first reported a position in CMLTU in Q2 2021 and held it in 1 quarter. The position peaked at $13.7M in Q2 2021. 28 funds tracked by Wall St. Rank hold CMLTU as of Q3 2021.

  • D.E. Shaw & Co reported no remaining CM Life Sciences III Inc. Unit position as of Q3 2021 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,250,000 CM Life Sciences III Inc. Unit shares in Q3 2021, an estimated $13.7M.
  • D.E. Shaw & Co first reported a position in CM Life Sciences III Inc. Unit in Q2 2021 and held it in 1 quarter.
  • D.E. Shaw & Co's CM Life Sciences III Inc. Unit position peaked at $13.7M in Q2 2021.
  • 28 funds tracked by Wall St. Rank held CM Life Sciences III Inc. Unit as of Q3 2021.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.